Estimation of vaccine effectiveness using the screening methodFARRINGTON, C. P.International journal of epidemiology. 1993, Vol 22, Num 4, pp 742-746, issn 0300-5771Article

Optimal screening policies for hepatitis AFARRINGTON, C. P.The Journal of the Operational Research Society. 1989, Vol 40, Num 4, pp 355-359, issn 0160-5682, 5 p.Article

The measurement and interpretation of age-specific vaccine efficacyFARRINGTON, C. P.International journal of epidemiology. 1992, Vol 21, Num 5, pp 1014-1020, issn 0300-5771Article

Control without separate controls: evaluation of vaccine safety using case-only methodsFARRINGTON, C. P.Vaccine. 2004, Vol 22, Num 15-16, pp 2064-2070, issn 0264-410X, 7 p.Conference Paper

Interval estimation for Poisson capture-recapture models in epidemiologyFARRINGTON, C. P.Statistics in medicine. 2002, Vol 21, Num 20, pp 3079-3092, issn 0277-6715, 14 p.Article

Interval censored survival data : a generalized linear modelling approachFARRINGTON, C. P.Statistics in medicine. 1996, Vol 15, Num 3, pp 283-292, issn 0277-6715Article

On Assessing goodness of fit of generalized linear models to sparse dataFARRINGTON, C. P.Journal of the Royal Statistical Society. Series B. Methodological. 1996, Vol 58, Num 2, pp 349-360, issn 0035-9246Article

Vaccine trialsFARRINGTON, C. P; MILLER, E.Molecular biotechnology. 2001, Vol 17, Num 1, pp 43-58, issn 1073-6085Article

The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989MILLER, C; FARRINGTON, C. P; HARBERT, K et al.International journal of epidemiology. 1992, Vol 21, Num 5, pp 998-1006, issn 0300-5771Article

Inaccuracy of counts of organisms in water or other samples : effects of pre-dilutionTILLETT, H. E; FARRINGTON, C. P.Letters in applied microbiology. 1991, Vol 13, Num 3, pp 168-170, issn 0266-8254Article

Semiparametric analysis of case series dataFARRINGTON, C. P; WHITAKER, H. J.Applied statistics. 2006, Vol 55, pp 553-594, issn 0035-9254, 42 p., 5Article

Case series analysis of adverse reactions to vaccines : A comparative evaluationFARRINGTON, C. P; NASH, J; MILLER, E et al.American journal of epidemiology. 1996, Vol 143, Num 11, pp 1165-1173, issn 0002-9262Article

Matrix models for childhood infections : a Bayesian approach with applications to rubella and mumpsKANAAN, M. N; FARRINGTON, C. P.Epidemiology and infection. 2005, Vol 133, Num 6, pp 1009-1021, issn 0950-2688, 13 p.Article

Interval-censored survival data with informative examination times : Parametric models and approximate inferenceFARRINGTON, C. P; GAY, N. J.Statistics in medicine. 1999, Vol 18, Num 10, pp 1235-1248, issn 0277-6715Article

Within-subject exposure dependency in case-crossover studiesVINES, S. K; FARRINGTON, C. P.Statistics in medicine. 2001, Vol 20, Num 20, pp 3039-3049, issn 0277-6715Article

The distribution of time to extinction in subcritical branching processes : Applications to outbreaks of infectious diseaseFARRINGTON, C. P; GRANT, A. D.Journal of applied probability. 1999, Vol 36, Num 3, pp 771-779, issn 0021-9002Article

Epidemiological studies of the non-specific effects of vaccines: II - methodological issues in the design and analysis of cohort studiesFARRINGTON, C. P; FIRTH, M. J; MOULTON, L. H et al.TM & IH. Tropical medicine & international health. 2009, Vol 14, Num 9, pp 977-985, issn 1360-2276, 9 p.Article

Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine : Implications for immunization programsDOURADO, I; CUNHA, S; TEIXEIRA, M. Da G et al.American journal of epidemiology. 2000, Vol 151, Num 5, pp 524-530, issn 0002-9262Article

Autism and measles, mumps, and rubella vaccine : no epidemiological evidence for a causal associationTAYLOR, B; MILLER, E; FARRINGTON, C. P et al.Lancet (British edition). 1999, Vol 353, Num 9169, pp 2026-2029, issn 0140-6736Article

Deaths from variant Creutzfeldt-Jakob disease in the UKANDREWS, N. J; FARRINGTON, C. P; WARD, H. J. T et al.Lancet (British edition). 2003, Vol 361, Num 9359, pp 751-752, issn 0140-6736, 2 p.Article

The prevalence of hepatitis B infection in adults in England and WalesGAY, N. J; HESKETH, L. M; OSBORNE, K. P et al.Epidemiology and infection. 1999, Vol 122, Num 1, pp 133-138, issn 0950-2688Article

Vaccine coverage : recent trends and future prospectsWHITE, J. M; GILLAM, S. J; BEGG, N. T et al.BMJ. British medical journal (International ed.). 1992, Vol 304, Num 6828, pp 682-684, issn 0959-8146Article

Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practiceWELDESELASSIE, Y. G; WHITAKER, H. J; FARRINGTON, C. P et al.Epidemiology and infection. 2011, Vol 139, Num 12, pp 1805-1817, issn 0950-2688, 13 p.Article

Incidence of variant Creutzfeldt-Jakob disease in the UKANDREWS, N. J; FARRINGTON, C. P; COUSENS, S. N et al.Lancet (British edition). 2000, Vol 356, Num 9228, pp 481-482, issn 0140-6736Article

Hospital admissions attributable to rotavirus infection in England and WalesRYAN, M. J; RAMSAY, M; BROWN, D et al.The Journal of infectious diseases. 1996, Vol 174, pp S12-S18, issn 0022-1899, SUP1Conference Paper